ILD Co-morbidites, CVD and metabolic diseases

ILD_CVDMETABOCOMORB

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
ILD_CVDMETABOCOMORB

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 142534 63237 79297
Unadjusted prevalence (%) 40.06 31.87 50.39
Mean age at first event (years) 57.29 55.88 58.42

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 4.75 [4.46, 5.05] <1e-100 27581
15 years 0.02 3.25 [3.03, 3.48] <1e-100 11906
5 years 0.00 4.69 [4.35, 5.06] <1e-100 5760
1 year 0.00 22.78 [19.93, 26.04] <1e-100 5029

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: ILD_CVDMETABOCOMORB – ILD Co-morbidites, CVD and metabolic diseases
GWS hits:

Survival analyses between endpoints

Plot

before ILD Co-morbidites, CVD and metabolic diseases
after ILD Co-morbidites, CVD and metabolic diseases

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after ILD Co-morbidites, CVD and metabolic diseases